Spots Global Cancer Trial Database for The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population
Official Title:
Study ID: NCT01490541
Conditions
Interventions
Study Description
Brief Summary: The predictive scores for gastric cancer in gastric intestinal metaplasia(GIM) patient: a recommendation for Thai population. Objective: To evaluate major risk factors for gastric cancer in gastric intestinal metaplasia(GIM) patient in order to propose the appropriate recommendation for Thai people. Research Design: Single center, retrospective-cohort study.
Detailed Description: Study population and Sample size at Faculty of Medicine, Chulalongkorn University The patients who were diagnosed gastric intestinal metaplasia from 1997 to 2012 and then follow up for 5 years. Estimate sample size =280 * Investigational product, dosage \& route of administration * Questionnaire for explore the risk factors * EGD with biopsy * Blood sampling for gastro panel * Duration of participation * 5 years or until diagnose gastric cancer Statistical method: Unconditional-binary-logistic regression
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Rapat Pittayanon, Bangkok, , Thailand
Contact Details
Name: Rungsun Rerknimitr, Professor
Affiliation: King Chulalongkorn Memorial Hospital
Role: STUDY_DIRECTOR
Name: Rapat Pittayanon, MD
Affiliation: King Chulalongkron Memorial Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
